1	Lipopolysaccharide	Lipopolysaccharide	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	potent	potent	_	_	_	_	_	_	_
5	monocyte/macrophage-specific	monocyte/macrophage-specific	_	_	_	_	_	_	_
6	stimulator	stimulator	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
10	virus	virus	_	_	_	_	_	_	_
11	type	type	_	_	_	_	_	_	_
12	1	1	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Lipopolysaccharide	Lipopolysaccharide	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	LPS	LPS	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	potently	potently	_	_	_	_	_	_	_
6	stimulates	stimulate	_	_	_	_	_	_	_
7	human	human	_	_	_	_	_	_	_
8	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
9	virus	virus	_	_	_	_	_	_	_
10	type	type	_	_	_	_	_	_	_
11	1-long	1-long	_	_	_	_	_	_	_
12	terminal	terminal	_	_	_	_	_	_	_
13	repeat	repeat	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	HIV-1-LTR	HIV-1-LTR	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	CAT	CAT	_	_	_	_	_	_	_
18	constructs	construct	_	_	_	_	_	_	_
19	transfected	transfecte	_	_	_	_	_	_	_
20	into	into	_	_	_	_	_	_	_
21	monocyte/macrophage-like	monocyte/macrophage-like	_	_	_	_	_	_	_
22	cell	cell	_	_	_	_	_	_	_
23	lines	line	_	_	_	_	_	_	_
24	but	but	_	_	_	_	_	_	_
25	not	not	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	T	t	_	_	_	_	_	_	_
28	cell	cell	_	_	_	_	_	_	_
29	line	line	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	effect	effect	_	_	_	_	_	_	_
3	appears	appear	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	be	be	_	_	_	_	_	_	_
6	mediated	mediate	_	_	_	_	_	_	_
7	through	through	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	induction	induction	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	nuclear	nuclear	_	_	_	_	_	_	_
12	factor	factor	_	_	_	_	_	_	_
13	kappa	kappa	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	NF-kappa	NF-kappa	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Electrophoretic	electrophoretic	_	_	_	_	_	_	_
2	mobility	mobility	_	_	_	_	_	_	_
3	shift	shift	_	_	_	_	_	_	_
4	assays	assay	_	_	_	_	_	_	_
5	demonstrate	demonstrate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	LPS	LPS	_	_	_	_	_	_	_
8	induces	induce	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	DNA	dna	_	_	_	_	_	_	_
11	binding	binding	_	_	_	_	_	_	_
12	activity	activity	_	_	_	_	_	_	_
13	indistinguishable	indistinguishable	_	_	_	_	_	_	_
14	from	from	_	_	_	_	_	_	_
15	NF-kappa	NF-kappa	_	_	_	_	_	_	_
16	B	B	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	U937	u937	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	THP-1	thp-1	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	LPS	LPS	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	also	also	_	_	_	_	_	_	_
4	shown	show	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	dramatically	dramatically	_	_	_	_	_	_	_
7	increase	increase	_	_	_	_	_	_	_
8	HIV-1	HIV-1	_	_	_	_	_	_	_
9	production	production	_	_	_	_	_	_	_
10	from	from	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	chronically	chronically	_	_	_	_	_	_	_
13	infected	infected	_	_	_	_	_	_	_
14	monocyte/macrophage-like	monocyte/macrophage-like	_	_	_	_	_	_	_
15	cloned	clone	_	_	_	_	_	_	_
16	cell	cell	_	_	_	_	_	_	_
17	line	line	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	U1	U1	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	which	which	_	_	_	_	_	_	_
22	produces	produce	_	_	_	_	_	_	_
23	very	very	_	_	_	_	_	_	_
24	low	low	_	_	_	_	_	_	_
25	levels	level	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	HIV-1	HIV-1	_	_	_	_	_	_	_
28	at	at	_	_	_	_	_	_	_
29	baseline	baseline	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	stimulation	stimulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	viral	viral	_	_	_	_	_	_	_
5	production	production	_	_	_	_	_	_	_
6	from	from	_	_	_	_	_	_	_
7	this	this	_	_	_	_	_	_	_
8	cell	cell	_	_	_	_	_	_	_
9	line	line	_	_	_	_	_	_	_
10	occurs	occur	_	_	_	_	_	_	_
11	only	only	_	_	_	_	_	_	_
12	if	if	_	_	_	_	_	_	_
13	these	these	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	are	be	_	_	_	_	_	_	_
16	treated	treat	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	granulocyte/macrophage	granulocyte/macrophage	_	_	_	_	_	_	_
19	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
20	factor	factor	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	GM-CSF	GM-CSF	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	before	before	_	_	_	_	_	_	_
25	treatment	treatment	_	_	_	_	_	_	_
26	with	with	_	_	_	_	_	_	_
27	LPS	LPS	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	stimulation	stimulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	HIV-1	HIV-1	_	_	_	_	_	_	_
5	production	production	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	correlated	correlate	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	increase	increase	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	level	level	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	HIV-1	HIV-1	_	_	_	_	_	_	_
16	RNA	RNA	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	NF-kappa	NF-kappa	_	_	_	_	_	_	_
22	B.	B.	_	_	_	_	_	_	_
23	LPS	LPS	_	_	_	_	_	_	_
24	is	be	_	_	_	_	_	_	_
25	not	not	_	_	_	_	_	_	_
26	able	able	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	induce	induce	_	_	_	_	_	_	_
29	HIV-1	HIV-1	_	_	_	_	_	_	_
30	production	production	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	a	a	_	_	_	_	_	_	_
33	cloned	clone	_	_	_	_	_	_	_
34	T	t	_	_	_	_	_	_	_
35	cell	cell	_	_	_	_	_	_	_
36	line	line	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	effect	effect	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	LPS	LPS	_	_	_	_	_	_	_
5	on	on	_	_	_	_	_	_	_
6	HIV-1	HIV-1	_	_	_	_	_	_	_
7	replication	replication	_	_	_	_	_	_	_
8	occurs	occur	_	_	_	_	_	_	_
9	at	at	_	_	_	_	_	_	_
10	picogram	picogram	_	_	_	_	_	_	_
11	per	per	_	_	_	_	_	_	_
12	milliliter	milliliter	_	_	_	_	_	_	_
13	concentrations	concentration	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	may	may	_	_	_	_	_	_	_
16	be	be	_	_	_	_	_	_	_
17	clinically	clinically	_	_	_	_	_	_	_
18	significant	significant	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	understanding	understand	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	variability	variability	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	natural	natural	_	_	_	_	_	_	_
26	history	history	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	HIV-1	HIV-1	_	_	_	_	_	_	_
29	infection	infection	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

